Fresenius Medical Care AG & Co. (Pref) (FME) Given a €83.00 Price Target at Deutsche Bank AG

Deutsche Bank AG set a €83.00 ($97.65) price target on Fresenius Medical Care AG & Co. (Pref) (ETR:FME) in a research report sent to investors on Friday, October 20th. The firm currently has a neutral rating on the stock.

FME has been the subject of several other research reports. Goldman Sachs Group, Inc. (The) set a €97.00 ($114.12) price objective on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a research note on Tuesday, August 8th. J P Morgan Chase & Co set a €95.10 ($111.88) price objective on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a report on Tuesday, August 8th. Commerzbank Ag set a €88.00 ($103.53) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a neutral rating in a report on Monday, August 7th. Kepler Capital Markets set a €95.00 ($111.76) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a report on Wednesday, August 2nd. Finally, Berenberg Bank set a €92.10 ($108.35) price objective on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a report on Monday, August 7th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and nine have given a buy rating to the company. Fresenius Medical Care AG & Co. (Pref) currently has a consensus rating of Hold and an average price target of €89.18 ($104.91).



Shares of Fresenius Medical Care AG & Co. (ETR:FME) opened at 83.959 on Friday. The stock has a market cap of €25.76 billion and a price-to-earnings ratio of 21.650. The stock has a 50 day moving average price of €82.10 and a 200-day moving average price of €82.37. Fresenius Medical Care AG & Co. has a 12-month low of €70.82 and a 12-month high of €89.07.

ILLEGAL ACTIVITY NOTICE: “Fresenius Medical Care AG & Co. (Pref) (FME) Given a €83.00 Price Target at Deutsche Bank AG” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another site, it was illegally copied and republished in violation of international copyright law. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2017/10/29/deutsche-bank-ag-analysts-give-fresenius-medical-care-ag-83-00-price-target.html.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply